Table of Contents Author Guidelines Submit a Manuscript
International Journal of Nephrology
Volume 2012, Article ID 239476, 7 pages
http://dx.doi.org/10.1155/2012/239476
Clinical Study

Serum Hepcidin Levels and Reticulocyte Hemoglobin Concentrations as Indicators of the Iron Status of Peritoneal Dialysis Patients

1Department of Medicine IV, Tokyo Women's Medical University, Kawada-cho 8-1, Shinjuku, Tokyo 162-8666, Japan
2Department of Nephrology, Kameda Medical Center, Higashi-machi 929, Kamogawa, Chiba 296-8602, Japan
3Immunology & Chemistry Product Engineering, ICH Business Unit, Sysmex Corporation, Wakihama, Kaigandori 1-5-1, Chuou-ku, Koube, Hyogo 651-0073, Japan
4Clinical Development, Technology Development, Sysmex Corporation, Wakihama, Kaigandori 1-5-1, Chuou-ku, Koube, Hyogo 651-0073, Japan

Received 24 July 2012; Accepted 27 September 2012

Academic Editor: Kook-Hwan Oh

Copyright © 2012 Aya Eguchi et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R. Deicher and W. H. Hörl, “Hepcidin: a molecular link between inflammation and anaemia,” Nephrology Dialysis Transplantation, vol. 19, no. 3, pp. 521–524, 2004. View at Publisher · View at Google Scholar · View at Scopus
  2. G. Nicolas, C. Chauvet, L. Viatte et al., “The gene encoding the iron regulatory peptide hepcidin is regulated by anemia, hypoxia, and inflammation,” Journal of Clinical Investigation, vol. 110, no. 7, pp. 1037–1044, 2002. View at Publisher · View at Google Scholar · View at Scopus
  3. G. Weiss and L. T. Goodnough, “Anemia of chronic disease,” The New England Journal of Medicine, vol. 352, no. 10, pp. 1011–1023, 2005. View at Publisher · View at Google Scholar · View at Scopus
  4. N. Tomosugi, H. Kawabata, R. Wakatabe et al., “Detection of serum hepcidin in renal failure and inflammation by using ProteinChip System,” Blood, vol. 108, no. 4, pp. 1381–1387, 2006. View at Publisher · View at Google Scholar · View at Scopus
  5. S. Fishbane, C. Galgano, R. C. Langley Jr., W. Canfield, and J. K. Maesaka, “Reticulocyte hemoglobin content in the evaluation of iron status of hemodialysis patients,” Kidney International, vol. 52, no. 1, pp. 217–222, 1997. View at Google Scholar · View at Scopus
  6. C. Brugnara, B. Schiller, and J. Moran, “Reticulocyte hemoglobin equivalent (Ret He) and assessment of iron-deficient states,” Clinical and Laboratory Haematology, vol. 28, no. 5, pp. 303–308, 2006. View at Publisher · View at Google Scholar · View at Scopus
  7. N. Miwa, T. Akiba, N. Kimata et al., “Usefulness of measuring reticulocyte hemoglobin equivalent in the management of haemodialysis patients with iron deficiency,” International Journal of Laboratory Hematology, vol. 32, no. 2, pp. 248–255, 2010. View at Publisher · View at Google Scholar · View at Scopus
  8. L. Thomas, S. Franck, M. Messinger, J. Linssen, M. Thomé, and C. Thomas, “Reticulocyte hemoglobin measurement—comparison of two methods in the diagnosis of iron-restricted erythropoiesis,” Clinical Chemistry and Laboratory Medicine, vol. 43, no. 11, pp. 1193–1202, 2005. View at Publisher · View at Google Scholar · View at Scopus
  9. T. Uehata, N. Tomosugi, T. Shoji et al., “Serum hepcidin-25 levels and anemia in non-dialysis chronic kidney disease patients: a cross-sectional study,” Nephrology Dialysis Transplantation, vol. 27, no. 3, pp. 1076–1083, 2012. View at Google Scholar
  10. I. C. Macdougall, J. Malyszko, R. C. Hider, and S. S. Bansal, “Current status of the measurement of blood hepcidin levels in chronic kidney disease,” Clinical Journal of the American Society of Nephrology, vol. 5, no. 9, pp. 1681–1689, 2010. View at Publisher · View at Google Scholar · View at Scopus
  11. D. R. Ashby, D. P. Gale, M. Busbridge et al., “Plasma hepcidin levels are elevated but responsive to erythropoietin therapy in renal disease,” Kidney International, vol. 75, no. 9, pp. 976–981, 2009. View at Publisher · View at Google Scholar · View at Scopus
  12. A. Kato, T. Tsuji, J. Luo, Y. Sakao, H. Yasuda, and A. Hishida, “Association of prohepcidin and hepcidin-25 with erythropoietin response and ferritin in hemodialysis patients,” American Journal of Nephrology, vol. 28, no. 1, pp. 115–121, 2007. View at Publisher · View at Google Scholar · View at Scopus
  13. L. Valenti, D. Girelli, G. F. Valenti et al., “HFE mutations modulate the effect of iron on serum hepcidin-25 in chronic hemodialysis patients,” Clinical Journal of the American Society of Nephrology, vol. 4, no. 8, pp. 1331–1337, 2009. View at Publisher · View at Google Scholar · View at Scopus
  14. H. P. E. Peters, C. M. M. Laarakkers, D. W. Swinkels, and J. F. M. Wetzels, “Serum hepcidin-25 levels in patients with chronic kidney disease are independent of glomerular filtration rate,” Nephrology Dialysis Transplantation, vol. 25, no. 3, pp. 848–853, 2010. View at Publisher · View at Google Scholar · View at Scopus
  15. J. Zaritsky, B. Young, H. J. Wang et al., “Hepcidin—a potential novel biomarker for iron status in chronic kidney disease,” Clinical Journal of the American Society of Nephrology, vol. 4, no. 6, pp. 1051–1056, 2009. View at Publisher · View at Google Scholar · View at Scopus
  16. J. L. Babitt and H. Y. Lin, “Molecular mechanisms of hepcidin regulation: implications for the anemia of CKD,” American Journal of Kidney Diseases, vol. 55, no. 4, pp. 726–741, 2010. View at Publisher · View at Google Scholar · View at Scopus
  17. J. Malyszko, J. S. Malyszko, K. Pawlak, L. Drozdowska-Rams, S. Brzosko, and M. Mysliwiec, “Hepcidin Is linked to anemia and inflammation in peritoneal dialysis patients,” Peritoneal Dialysis International, vol. 28, no. 4, pp. 418–421, 2008. View at Google Scholar · View at Scopus
  18. J. Malyszko, J. S. Malyszko, P. Kozminski, and M. Mysliwiec, “Type of renal replacement therapy and residual renal function may affect prohepcidin and hepcidin,” Renal Failure, vol. 31, no. 10, pp. 876–883, 2009. View at Publisher · View at Google Scholar · View at Scopus
  19. T. Ganz, “Molecular control of iron transport,” Journal of the American Society of Nephrology, vol. 18, no. 2, pp. 394–400, 2007. View at Publisher · View at Google Scholar · View at Scopus
  20. E. Nemeth, M. S. Tuttle, J. Powelson et al., “Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization,” Science, vol. 306, no. 5704, pp. 2090–2093, 2004. View at Publisher · View at Google Scholar · View at Scopus
  21. M. W. Hentze, M. U. Muckenthaler, B. Galy, and C. Camaschella, “Two to tango: regulation of mammalian iron metabolism,” Cell, vol. 142, no. 1, pp. 24–38, 2010. View at Publisher · View at Google Scholar · View at Scopus
  22. D. W. Coyne, “Hepcidin: clinical utility as a diagnostic tool and therapeutic target,” Kidney International, vol. 80, no. 3, pp. 240–244, 2011. View at Publisher · View at Google Scholar · View at Scopus
  23. B. Young and J. Zaritsky, “Hepcidin for clinicians,” Clinical Journal of the American Society of Nephrology, vol. 4, no. 8, pp. 1384–1387, 2009. View at Publisher · View at Google Scholar · View at Scopus
  24. I. C. Macdougall, R. D. Hutton, I. Cavill, G. A. Coles, and J. D. Williams, “Poor response to treatment of renal anaemia with erythropoietin corrected by iron given intravenously,” British Medical Journal, vol. 298, no. 6692, pp. 157–158, 1989. View at Google Scholar · View at Scopus
  25. D. B. Van Wyck, J. C. Stivelman, J. Ruiz, L. F. Kirlin, M. A. Katz, and D. A. Ogden, “Iron status in patients receiving erythropoietin for dialysis-associated anemia,” Kidney International, vol. 35, no. 2, pp. 712–716, 1989. View at Google Scholar · View at Scopus
  26. G. Papanikolaou, M. Tzilianos, J. I. Christakis et al., “Hepcidin in iron overload disorders,” Blood, vol. 105, no. 10, pp. 4103–4105, 2005. View at Publisher · View at Google Scholar · View at Scopus
  27. E. Nemeth, S. Rivera, V. Gabayan et al., “IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin,” Journal of Clinical Investigation, vol. 113, no. 9, pp. 1271–1276, 2004. View at Publisher · View at Google Scholar · View at Scopus